These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 8580481)
41. [Development of a fusion toxin IL15M-PEdelta293 based on a receptor-specific IL-15 antagonist]. Niu YF; Zheng Y; Mao XH Sheng Wu Gong Cheng Xue Bao; 2005 Jan; 21(1):42-6. PubMed ID: 15859327 [TBL] [Abstract][Full Text] [Related]
42. Construction and expression of high efficiency expressing plasmid of transforming growth factor alpha-Pseudomonas aeruginosa exotoxin fusion protein TGF alpha-PE40. Xu Y; Shen M; Zhao Q; Zhang H; Xu Y Chin J Biotechnol; 1994; 10(4):233-9. PubMed ID: 7780019 [TBL] [Abstract][Full Text] [Related]
43. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice. Siegall CB; Kreitman RJ; FitzGerald DJ; Pastan I Cancer Res; 1991 Jun; 51(11):2831-6. PubMed ID: 1851660 [TBL] [Abstract][Full Text] [Related]
44. [Construction and prokaryotic expression of a recombinant immunotoxin fused with mouse interleukin 18 and truncated Pseudomonas exotoxin]. Li H; Li MY; Jiang ZH; Lü ML; Zhang L Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):753-6. PubMed ID: 15573745 [TBL] [Abstract][Full Text] [Related]
45. Targeted Fc2'-3-PE40 chimeric protein abolishes passive cutaneous anaphylaxis in mice. Fishman A; Prus D; Belostotsky R; Lorberboum-Galski H Clin Exp Immunol; 2000 Mar; 119(3):398-403. PubMed ID: 10691909 [TBL] [Abstract][Full Text] [Related]
46. [Construction and expression of the fusion protein DT389-hIL-13 and its cytotoxicity to glioma cell lines]. Tuo HZ; Wang JW; Wang DX; Li JM; Ouyang J; Hong T Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1024-8. PubMed ID: 15312540 [TBL] [Abstract][Full Text] [Related]
47. Cytotoxicity of TGF alpha-PE40 and correlation to expression of epidermal growth factor receptor. Berger DP; Herbstritt L; Hellerich U; Schulzke S; Dengler WA; Gallo M; Pastan I; Mertelsmann R; Fiebig HH Eur J Cancer; 1995 Nov; 31A(12):2067-72. PubMed ID: 8562167 [TBL] [Abstract][Full Text] [Related]
48. Single-chain fusion toxins for the treatment of breast cancer: antitumor activity of BR96 sFv-PE40 and heregulin-PE40. Siegall CB Recent Results Cancer Res; 1996; 140():51-60. PubMed ID: 8787077 [No Abstract] [Full Text] [Related]
49. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages. Ashorn P; Englund G; Martin MA; Moss B; Berger EA J Infect Dis; 1991 Apr; 163(4):703-9. PubMed ID: 2010626 [TBL] [Abstract][Full Text] [Related]
50. Ocular distribution of the chimeric protein IL2-PE40. BenEzra D; Maftzir G; Hochberg E; Anteby I; Lorberboum-Galski H Curr Eye Res; 1995 Feb; 14(2):153-8. PubMed ID: 7768107 [TBL] [Abstract][Full Text] [Related]
51. Interleukin-2 Pseudomonas exotoxin chimeric protein is cytotoxic to B cell cultures derived from myasthenia gravis patients. Steinberger I; Brenner T; Lorberboum-Galski H J Neurol Sci; 1995 Nov; 133(1-2):183-91. PubMed ID: 8583224 [TBL] [Abstract][Full Text] [Related]
52. Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40. Verhoef J; Gekker G; Erice A; Peterson PK; Balfour HH Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):715-21. PubMed ID: 1425730 [TBL] [Abstract][Full Text] [Related]
53. Purification of the IL-2 receptor (TAC) by ligand-affinity chromatography and utilization of the immobilized receptor for receptor-affinity chromatography (RAC) purification of IL-2, mutant IL-2, and IL-2 fusion proteins. Smart JE; Familletti PC; Weber DV; Keeney RF; Bailon P J Invest Dermatol; 1990 Jun; 94(6 Suppl):158S-163S. PubMed ID: 2351848 [TBL] [Abstract][Full Text] [Related]
54. Membrane-based receptor affinity chromatography. Nachman M; Azad AR; Bailon P J Chromatogr; 1992 Apr; 597(1-2):155-66. PubMed ID: 1517311 [TBL] [Abstract][Full Text] [Related]
55. Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. Lorberboum-Galski H; FitzGerald D; Chaudhary V; Adhya S; Pastan I Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1922-6. PubMed ID: 3126499 [TBL] [Abstract][Full Text] [Related]
56. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response. Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661 [TBL] [Abstract][Full Text] [Related]
57. Cardiac allograft survival in mice treated with IL-2-PE40. Lorberboum-Galski H; Barrett LV; Kirkman RL; Ogata M; Willingham MC; FitzGerald DJ; Pastan I Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1008-12. PubMed ID: 2644640 [TBL] [Abstract][Full Text] [Related]
58. Increased cytotoxicity of interleukin 2-pseudomonas exotoxin (IL2-PE) chimeric proteins containing a targeting signal for lysosomal membranes. Fishman A; Bar-Kana Y; Steinberger I; Lorberboum-Galski H Biochemistry; 1994 May; 33(20):6235-43. PubMed ID: 8193138 [TBL] [Abstract][Full Text] [Related]
59. Cloning and expression of the gene coding for IL-2(60)-PE40, a molecular targeted protein. Zhang M; Zhao X; Li H; Lu S Chin Med Sci J; 1995 Sep; 10(3):136-40. PubMed ID: 8580481 [TBL] [Abstract][Full Text] [Related]